[1]
Somani, A. , Ibrahim, S. , Tassavor, M. , Yoo, J. and Farberg, A. 2024. Use of the 40-Gene Expression Profile (40-GEP) Test in Medicare-Eligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs . SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s336. DOI:https://doi.org/10.25251/skin.8.supp.336.